products

Quanterix Instruments

Quanterix’ technology is designed to enable much earlier disease detection, better prognoses, and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come.

The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease.

HD-X Analyzer™

Delivering Ultrasensitive Biomarker Measurement You Can Count On

The latest model is a fully automated Simoa® bead-based immunoassay platform. HD-X delivers major productivity improvements, greater user flexibility, unparalleled sensitivity, and best-in-class assay performance across a broad assay menu to empower biomarker research and accelerate drug development.

SP-X Imaging and Analysis System™

Simoa-sensitive™ multiplex biomarker measurement detection

Access Simoa-sensitive biomarker detection capabilities using the Simoa® planar array platform, in a compact, affordable system.

SR-X™ Biomarker Detection System

Single molecule detection in a benchtop instrument

Access ultra-sensitive bead-based technology in a compact benchtop system.

The 2470 Arrayer

Quality, Reliability, Flexibility and True Walk-Away Automation in Mind

Produces high quality microarrays of DNA, proteins, cell lysates and a variety of other samples using its proprietary soft touch deposition technology.

Simoa® Bead and Planar Array Assays

Our broad portfolio of available kits spans multiple therapeutic areas including cardiology, infectious disease, inflammation, neurology, and oncology. Choose from our readily-available kits or our homebrew option.

Ready-to-use Simoa kits contain all the reagents necessary to run your assay on the HD-X, HD-1, SR-X or new SP-X platform. Our unique homebrew capabilities provide the flexibility for researchers to develop custom Simoa Bead or Planar Array assays.

Uman Diagnostics Assays & Reagents

UmanDiagnostics, a division of Quanterix, supplies NF-Light™ antibodies and ELISA kits, which are widely recognized by researchers and biopharmaceutical and diagnostics companies world-wide as the premier solution for the detection of NF-Light to advance the development of therapeutics and diagnostics for neurodegenerative conditions.

services

Simoa® Accelerator Laboratory

Greater depths of contract research at your reach

With the Simoa® Accelerator Laboratory as your pharma service technology solution of choice, you can expand the limits of biomarker exploration and dramatically accelerate the timeline to drug approvals.

The Simoa Accelerator Laboratory

  • CLIA-Certified Laboratory
  • Offers the technology for single-plex and multiplex detection
  • Infrastructure allows scalability to handle sample sets
  • Develops robust SOPs and LIMS for project/sample tracking
  • Delivers quick turn-around with the flexibility to adjust project scope
  • Onsite assay development training through a 4-day program